Communities and Collections

Melatonin for cognitive impairment (Protocol)

  • Author(s) / Creator(s)
  • This is the protocol for a review and there is no abstract. The objectives are as follows: The primary objective is a systematic review of evidence relating to the clinical efficacy and safety of melatonin in the treatment of manifestations of dementia or cognitive impairment (CI).

  • Date created
  • Subjects / Keywords
  • Type of Item
    Article (Published)
  • DOI
  • License
    © 2005 The Cochrane Collaboration for John Wiley & Sons, Ltd. This version of this article is open access and can be downloaded and shared. The original author(s) and source must be cited.
  • Language
  • Citation for previous publication
    • Forbes D, Jansen SL, Duncan V, Morgan DG. (2005). Melatonin for cognitive impairment (Protocol). The Cochrane Database of Systematic Reviews, Issue 2, Art. No.: CD003802. DOI: 10.1002/14651858.CD003802.pub2.